922. Cost-effectiveness of baloxavir marboxil versus oseltamivir or no treatment for the management of influenza in the United States

BACKGROUND: Influenza poses a significant burden that can be effectively mitigated with antivirals. Baloxavir marboxil is an oral, single dose first-in-class endonuclease inhibitor that improves influenza symptoms and rapidly reduces virus shedding, shortening the infectious period and potentially r...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansen, Svenn, Cheng, Shih-Chen, Surinach, Andy, Yau, Vince, Best, Jennie H, Zaraket, Hassan, Zhou, Hao, Zumofen, Marie-Helene Blanchet
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679070/
http://dx.doi.org/10.1093/ofid/ofad500.967

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10679070/
http://dx.doi.org/10.1093/ofid/ofad500.967

Ejemplares similares